Value-Based Care Is Not Failing. The Contracts Are.

After a decade of value-based care experiments, the conventional wisdom is that the model has underperformed. Hospitals say the math does not work. Payers say providers are not changing behavior. Policymakers are quietly walking back the boldest claims.

From inside a 14-hospital system, the reality is more specific and more fixable than that narrative suggests. Value-based care is not failing. The contracts are.

What works

The clinical interventions that value-based care was supposed to incentivize do work. Care management for high-risk patients reduces admissions. Pharmacist-led medication reconciliation cuts readmissions. Embedded behavioral health reduces total cost of care. We have run these programs at scale and the outcomes are real.

The problem is not the medicine. The problem is the contract structure that is supposed to pay for it.

Where the contracts break

Most value-based contracts share three structural problems that make it nearly impossible for a provider organization to invest with confidence.

First, attribution rules are unstable. A patient who was attributed to us in January may be reassigned in March because they saw a specialist twice. Care management does not generate ROI in eight weeks, and the math collapses when patients churn out of your panel mid-cycle.

Second, benchmarks reward regression to the mean. The systems that have already done the easy work see their benchmarks tightened to the point where further savings are nearly impossible. The systems that have done nothing have enormous headroom. This is backwards.

Third, the reconciliation timeline is too long. A program launched in Q1 is settled financially fourteen to twenty months later. By the time the data comes back, the leadership team that approved the investment may have moved on, and the institutional memory of what worked is gone.

What would actually move the needle

Fix attribution first. A patient should be attributed for a defined period, regardless of where they receive care during the year. Without that, no rational CFO will fund a multi-year care management program.

Reset benchmarks against absolute targets, not historical trend. Otherwise the contract punishes prior performance.

Shorten reconciliation. Even quarterly true-ups would change the investment calculus dramatically.

None of these changes require new legislation. They require payers and provider organizations to negotiate contracts that align with how clinical change actually happens.

What we owe the next decade

The public conversation has started treating value-based care as a failed experiment. From where I sit, that is a dangerous conclusion. The interventions work. The patients benefit. The contracts are the bottleneck.

If we walk away now, we will have spent a decade learning what to do and a second decade pretending we did not learn it.